Engrave Wealth Partners’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
– Sell
-95
Closed -$7K – 205
2020
Q2
$7K Buy
95
+25
+36% +$2.01K 0.01% 284
2020
Q1
$4K Buy
+70
New +$5.37K ﹤0.01% 289

Other funds holding GH

Engrave Wealth Partners's GH Position: Q3 2020 in Review

Engrave Wealth Partners sold out of Guardant Health (GH) in Q3 2020, closing a stake of 95 shares — an estimated $7K sold.

Engrave Wealth Partners first reported a position in GH in Q1 2020 and held it in 2 quarters. The position peaked at $7K in Q2 2020. 346 funds tracked by Wall St. Rank hold GH as of Q3 2020.

  • Engrave Wealth Partners reported no remaining Guardant Health position as of Q3 2020 after selling out during the quarter.
  • Engrave Wealth Partners sold 95 Guardant Health shares in Q3 2020, an estimated $7K.
  • Engrave Wealth Partners first reported a position in Guardant Health in Q1 2020 and held it in 2 quarters.
  • Engrave Wealth Partners's Guardant Health position peaked at $7K in Q2 2020.
  • 346 funds tracked by Wall St. Rank held Guardant Health as of Q3 2020.

Based on Engrave Wealth Partners's 13F filing for Q3 2020, filed 8 Oct 2020.